5-methyl-2-(2-methylphenyl)-2,3-dihydro-1H-pyrazol-3-one, 97%, 500mg

2-(((3aR,4S,6R,6aS)-6-((5-Amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol, 98%, 1g

Z-DAPe.HCl, 99.0%, 1g

5-Bromo-1,4-dimethyl-1H-indazole, 95.0%, 1g

Ethyl 6-((tert-butoxycarbonyl)amino)spiro[3.3]heptane-2-carboxylate, 95.0%, 100mg

3-Bromo-1-methyl-1H-indole-2-carboxylic acid, 98%, 1g

2-[(4-Bromophenoxy)methyl]oxirane>97.0%(GC)5g

2-((tert-Butoxycarbonyl)amino)-2-(piperidin-4-yl)acetic acid, 95.0%, 1g

6-Fluoro-4-chromanone, 99.0%, 10g

4-Oxo-6-(thiophen-2-yl)-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile, 98%, 100mg

Fmoc-L-propargilglicina, PEPTIPURE®, mínimo 99 %, para bioquímica, 250 mg, envase de vidrio

2-Phenylisoindole-1,3-dione, 95.0%, 25g

5-(2-methylphenyl)-1H-pyrazole, 95.0%, 5g